The Print on MSN
How 1st FDA approved once-a-day pill to lower ‘bad’ cholesterol could shift treatment from statins
FDA has approved Lipfendra, developed by American pharmaceutical company Merck, for adults with high LDL cholesterol. It ...
Chicago Cubs outfielder Pete Crow-Armstrong recognized Los Angeles Dodgers superstar Shohei Ohtani as a continual MVP ...
"I’m the one that has to live in my body, I’m doing what I need to get my life back, and that’s all that matters." ...
A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...
The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The US FDA has given the green light to the world's first oral PCSK9 inhibitor, a groundbreaking medication that promises a ...
Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously ...
Trisha Paytas bought herself a pair of Christian Louboutin heels after undergoing a hemorrhoid removal procedure at a ...
The FDA has approved a first-of-its-kind pill that can lower "bad" LDL cholesterol with a daily pill instead of a shot.
The U.S. Food and Drug Administration has approved Merck's Lipfendra (enlicitide), making it the first oral PCSK9 inhibitor ...
HealthDay on MSN
FDA clears first cholesterol pill to rival costly injections
Key Takeaways The U.S. Food and Drug Administration approved Lipfendra, the first pill that blocks a cholesterol-raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results